Propecia (Finasteride) 1mg


Application: oral

Dosage: 1mg

Packing: 30 tablets

Product Description

Finasteride that is a specific inhibitor of 5a-reductase. Proscar is the enzyme responsible for converting testosterone into DHT (dihydrotestosterone). Proscar can efficiently reduce the serum concentration of DHT, therefore Proscar minimizes the unwanted androgenic effects that result from its presence. Propecia is the same drug but the tablet contains only 115 of the Proscar dosage. Scientists have long believed that DHT was the main Finasteride culprit in many cases of male hair loss (along with genetic factors), so there was little doubt after the release of Proscar that Finasteride would eventually be used for this purpose.


Benign prostatic hyperplasia (to reduce prostate size, improve urine flow and reduce symptoms associated with hyperplasia, reduce the risk of acute urinary retention requiring catheterization or surgery, including transurethral resection of the prostate and prostatectomy).
Prostate adenoma
  • Ask a question to the urologist
  • Buy medicines
  • View institutions


Hypersensitivity to finasteride, obstructive uropathy, cancer of the prostate. Finasteride is not used in women and children.


The daily dose is 5 mg, the frequency of administration is 1 time / day. Treatment is long.

Side effects

On the part of the reproductive system: rarely – impotence, decreased libido, decreased ejaculate volume, gynecomastia.

Allergic reactions: skin rash, angioedema.

Drug Interactions

There was no clinically significant interaction of finasteride with propranolol, digoxin , glyburide, warfarin, theophylline and antipyrin.

It seems that finasteride does not significantly affect the enzymatic system of cytochrome P450 and, accordingly, does not affect the pharmacokinetic indices of drugs metabolized by microsomal liver enzymes.

With simultaneous application of finasteride with ACE inhibitors, alpha-blockers, beta-blockers, calcium channel blockers , nitrates, diuretics, blockers of histamine H 2 receptor antagonists, inhibitors of HMG-KoA reductase inhibitors, NSAIDs, quinolones and benzodiazepines no clinically significant drug interactions.